Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 5 | 2023 | 222 | 1.710 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 420 | 1.480 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2019 | 488 | 0.900 |
Why?
|
| Esophagectomy | 2 | 2015 | 71 | 0.830 |
Why?
|
| Esophageal Neoplasms | 3 | 2015 | 392 | 0.710 |
Why?
|
| Adenocarcinoma | 4 | 2015 | 986 | 0.650 |
Why?
|
| Urologic Neoplasms | 1 | 2018 | 30 | 0.570 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1796 | 0.550 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 144 | 0.530 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 160 | 0.530 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 124 | 0.520 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 463 | 0.460 |
Why?
|
| Esophagogastric Junction | 1 | 2015 | 36 | 0.450 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1300 | 0.430 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 613 | 0.430 |
Why?
|
| Neoadjuvant Therapy | 4 | 2018 | 394 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 754 | 0.350 |
Why?
|
| Laparoscopy | 1 | 2015 | 541 | 0.310 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 576 | 0.280 |
Why?
|
| Survival Analysis | 3 | 2019 | 1498 | 0.250 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 706 | 0.240 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 318 | 0.240 |
Why?
|
| Aged | 10 | 2021 | 20895 | 0.220 |
Why?
|
| Middle Aged | 10 | 2021 | 28385 | 0.200 |
Why?
|
| Prognosis | 4 | 2017 | 4894 | 0.200 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2018 | 392 | 0.180 |
Why?
|
| Kidney | 2 | 2018 | 1283 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6781 | 0.160 |
Why?
|
| Cystectomy | 2 | 2018 | 141 | 0.160 |
Why?
|
| Survival Rate | 2 | 2015 | 2131 | 0.150 |
Why?
|
| Gene Editing | 2 | 2019 | 227 | 0.150 |
Why?
|
| Humans | 18 | 2023 | 130433 | 0.150 |
Why?
|
| Glia Maturation Factor | 1 | 2019 | 1 | 0.150 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 56 | 0.150 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 33 | 0.150 |
Why?
|
| Male | 9 | 2019 | 64535 | 0.140 |
Why?
|
| BCG Vaccine | 1 | 2019 | 110 | 0.140 |
Why?
|
| Ferritins | 1 | 2019 | 108 | 0.140 |
Why?
|
| Interleukin-33 | 1 | 2018 | 21 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 61 | 0.140 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 53 | 0.140 |
Why?
|
| Tryptases | 1 | 2018 | 17 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 118 | 0.140 |
Why?
|
| Melanoma | 2 | 2015 | 918 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 899 | 0.140 |
Why?
|
| Female | 9 | 2019 | 70291 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 131 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 125 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 138 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1607 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 426 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 191 | 0.130 |
Why?
|
| Nephrectomy | 1 | 2018 | 156 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 391 | 0.130 |
Why?
|
| Neuroglia | 1 | 2019 | 223 | 0.130 |
Why?
|
| Receptors, Growth Factor | 1 | 2016 | 36 | 0.130 |
Why?
|
| Anilides | 1 | 2016 | 52 | 0.120 |
Why?
|
| Drug Approval | 1 | 2016 | 46 | 0.120 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 56 | 0.120 |
Why?
|
| Cisplatin | 1 | 2018 | 271 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 442 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 288 | 0.120 |
Why?
|
| Quinolines | 1 | 2016 | 117 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2019 | 381 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 161 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 67 | 0.110 |
Why?
|
| Astrocytes | 1 | 2018 | 284 | 0.110 |
Why?
|
| Pyridines | 1 | 2016 | 259 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 322 | 0.110 |
Why?
|
| Biopsy | 1 | 2018 | 1239 | 0.110 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 129 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 427 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 160 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2015 | 240 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2018 | 753 | 0.100 |
Why?
|
| Propensity Score | 1 | 2014 | 272 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 194 | 0.100 |
Why?
|
| Adult | 6 | 2021 | 31128 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 303 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2207 | 0.090 |
Why?
|
| Inflammation | 1 | 2019 | 1474 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 876 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1604 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2018 | 722 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 296 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 982 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 1606 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 9995 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2298 | 0.080 |
Why?
|
| Cytokines | 1 | 2015 | 1335 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 3395 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17615 | 0.070 |
Why?
|
| Machine Learning | 2 | 2023 | 385 | 0.070 |
Why?
|
| Neurons | 1 | 2018 | 2014 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12860 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 3191 | 0.060 |
Why?
|
| Apoptosis | 1 | 2013 | 1842 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 1312 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5069 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 2107 | 0.050 |
Why?
|
| Risk Factors | 2 | 2018 | 10942 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1543 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2021 | 319 | 0.040 |
Why?
|
| United States | 1 | 2015 | 11827 | 0.040 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2019 | 5 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2018 | 38 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 154 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2018 | 93 | 0.030 |
Why?
|
| Mast Cells | 1 | 2018 | 66 | 0.030 |
Why?
|
| Animals | 4 | 2019 | 33907 | 0.030 |
Why?
|
| Standard of Care | 1 | 2018 | 131 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2919 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 512 | 0.030 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2015 | 12 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2015 | 64 | 0.030 |
Why?
|
| Immune System | 1 | 2015 | 99 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2015 | 143 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 569 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 718 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2579 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2015 | 225 | 0.030 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2013 | 2 | 0.030 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2013 | 17 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2013 | 32 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4674 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 61 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 78 | 0.020 |
Why?
|
| Etoposide | 1 | 2013 | 109 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 900 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 372 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 413 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 200 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 199 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 18197 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 767 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1215 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 2605 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1828 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4660 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2025 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 2847 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2477 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3717 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 20753 | 0.010 |
Why?
|